GlobeNewswire

Artelo Biosciences Presents ART26.12 Human Metabolite Data Demonstrating Favorable Drug Metabolism Characteristics Associated with Clinical Development Success
10/06/2026
Artelo’s lead medicinal chemist reveals findings at the Royal Society of Chemistry-BMCS/DMDG Medicinal Chemistry Conference in London SOLANA BEACH, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. ( [...]
Fedora Pharmaceuticals Expands Scientific Advisory Board with Appointment of Drs. Michael Dudley, Keith Micetich, and Jürgen Bulitta
10/06/2026
Drs. Dudley, Micetich, and Bulitta Join Existing Board of Renowned Infectious Disease Leaders in Common Goal of Advancing Fedora’s Lead Antibiotic Candidate Towards the Clinic EDMONTON, Alberta , June 10, 2026 (GLOBE [...]
Bluesight Awarded Pharmacy Technology Solutions Agreement with Premier, Inc.
10/06/2026
Alexandria, VA, USA, June 10, 2026 (GLOBE NEWSWIRE) -- Bluesight , the leader in hospital intelligence solutions, has been awarded a national group purchasing agreement for Pharmacy Technology Solutions with Premier, [...]
DataFirst, Inc. and Konica Minolta Healthcare Announce Partnership to Deliver Advanced Interoperability and DICOM Routing Solutions for the Healthcare Enterprise
10/06/2026
WAYNE, N.J. and RALEIGH, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- DataFirst and Konica Minolta Healthcare Americas, Inc. today announced the launch of superior interoperability solutions with Exa® PACS|RIS and Exa® [...]
Beacon Biosignals Unifies Brands, Bringing CleveMed and SleepView® Under the Beacon Name
10/06/2026
Beacon expands home sleep diagnostics with EEG-enabled testing through Waveband, building on CleveMed's established clinical and operational foundation. BOSTON, June 10, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today [...]
CONVOCATION A UNE ASSEMBLEE GENERALE EXTRAORDINAIRE D’IBA SA
10/06/2026
- - LUNDI 29 JUIN 2026 A 11H00 - - Cher Actionnaire, Le quorum requis pour la délibération et le vote sur les sujets à l'ordre du jour de l’assemblée générale extraordinaire des actionnaires de la Société qui était [...]
Urteste S.A. enrolls the first patient in the Panuri test clinical study
10/06/2026
Urteste S.A. enrolls the first patient in the Panuri test clinical study Gdańsk, Poland – 10 June 2026 – Urteste S.A. (Warsaw Stock Exchange: URT), a company developing innovative technology for the detection of cancer [...]
MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial
10/06/2026
Additional data from MAIA’s THIO-101 expansion may further support an accelerated approval filing with the FDA Potential breakthrough therapy holds substantial commercial opportunity in a projected $70 billion global [...]
Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.
10/06/2026
Study using Nexalin’s proprietary DIFS ™ 15 mA 77.5 Hz treatment platform demonstrated rapid, large-magnitude improvements in anxiety and depression with benefits maintained at 8-week follow-up Results further validate [...]
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial
10/06/2026
The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was completed under export authorization from Health Canada and [...]
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology
10/06/2026
Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve- [...]
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
10/06/2026
LITTLETON, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing- [...]
Physician Pay and Productivity Are Moving in Opposite Directions, MGMA Report Finds
10/06/2026
New benchmarks show compensation rising across all specialties in 2025 even as patient visits fell in all 23 core specialties and standard productivity measures declined in most — a disconnect driven by a worsening [...]
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
10/06/2026
CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR ® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc Per Protocol Analysis of Clinical Outcomes with Percutaneous 60-Day Medial Branch [...]
OneMedNet Executes on Growth Strategy: Secures Over $3 Million in New Bookings, Surpassing Full-Year 2025
10/06/2026
Strong Commercial Momentum Fueled by Demand for Regulatory-Grade Multi-Modal Real-World Data MINNEAPOLIS, June 10, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,” “us” or [...]
Tris Pharma Announces FDA Grant of Orphan Drug Designation for TRN-257 (Oxybate for Extended-Release Oral Suspension) a Once-Nightly, Low-Sodium Oxybate Product for Idiopathic Hypersomnia
10/06/2026
FDA grants Orphan Drug Designation (ODD) to Tris Pharma’s TRN-257 for the treatment of idiopathic hypersomnia, based on the plausible hypothesis that TRN-257 may be clinically superior to currently available oxybate [...]
CervoMed Announces Private Placement Financing and Plan to Focus on Strategic Partnering to Advance Neflamapimod into Phase 3 for Dementia with Lewy Bodies
10/06/2026
Additional funding will extend anticipated runway into second quarter of 2027 Strategic priority is to establish a partnership to advance neflamapimod into Phase 3 in dementia with Lewy bodies Anticipated pipeline [...]
Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases
10/06/2026
CLN-978 (CD19 TCE) EULAR data demonstrated potential for immune reset, including remissions, in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) CLN-978 data from the first RA multi-dose regimen [...]
BMGL to Effect Reverse Share Split on June 22, 2026
10/06/2026
SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), a medical clinic operator in Singapore, today announced that the Company’s board of directors has approved the [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum